A research team from the Broad institute, the University of British Columbia and 4Fusion Genomics Corporation have developed an open, free public browser […]
The Medical Association of Jamaica (MAJ) has apparently been doing their homework on the generic drug ivermectin and now have called […]
A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle East […]
The drug Huvemek, which contains the active ingredient ivermectin, is of great interest in hundreds of pharmacies across the country, […]
Although COVID-19 vaccines are now available for emergency use, that doesn’t preclude the desperate need for compelling, effective and safe […]
A group of South African doctors has taken on South African drug regulator known as SAHPRA to make ivermectin more accessible […]
A novel cancer drug known as EXO-CD24 developed and tested at Tel Aviv Sourasky Medical Center (Ichilov Hospital), demonstrates promising […]
The eastern African nation of Rwanda appears to be joining dozens of others nations worldwide and accepting Favipiravir as a […]
During the pandemic, TrialSite has reported multiple times on the potential for NeuroRX’s RLF-100 (aviptadil) currently under investigation and accessible […]
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), continues to invest […]
